SHANGBAY CAPITAL
Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta
SHANGBAY CAPITAL
Founded:
2015-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Caruso Ventures
Investing in High-Impact Scaleups, Seismic Trends and Next Generation Entrepreneurial Leaders
Fusion Fund
Fusion Fund invests in early stage companies with technological and data advantages in industrial, enterprise, and healthcare applications.
Susquehanna Growth Equity
Susquehanna Growth Equity invests in growth stage technology companies in the software, information services, and internet.
What If Ventures
What If Ventures invests primarily in mental health, addiction, and stigmatized healthcare services from seed stage to pre-IPO.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-07 | Huma.AI | Shangbay Capital investment in Series A - Huma.AI | 9.5 M USD |
| 2021-10-20 | Contraline | Shangbay Capital investment in Series A - Contraline | 10.7 M USD |
| 2021-09-01 | Laplace Interventional | Shangbay Capital investment in Series A - Laplace Interventional | 7.9 M USD |
| 2021-08-11 | Fluid Biomed Inc. | Shangbay Capital investment in Seed Round - Fluid Biomed Inc. | 4.7 M USD |
| 2021-07-27 | Neuro42 | Shangbay Capital investment in Series A - Neuro42 | 6.5 M USD |
| 2021-07-27 | IgGenix | Shangbay Capital investment in Series A - IgGenix | 25 M USD |
| 2021-05-25 | Emboline | Shangbay Capital investment in Series D - Emboline | 55 M USD |
| 2021-03-22 | EpimAb Biotherapeutics | Shangbay Capital investment in Series C - EpimAb Biotherapeutics | 120 M USD |
| 2021-01-27 | SetPoint Medical | Shangbay Capital investment in Venture Round - SetPoint Medical | 64 M USD |
| 2020-09-01 | Aqua Medical | Shangbay Capital investment in Series A - Aqua Medical | 8.2 M USD |
More informations about "Shangbay Capital"
Shangbay Capital - Crunchbase Investor Profile
Shangbay Capital invests in early to late-stage companies within the healthcare, medical device, and biotechnology sectors, focusing on the United States, particularly in Massachusetts, California, and Minnesota. Learn More. Find …See details»
ShangBay Capital - LinkedIn
ShangBay Capital is a venture capital company that brings both U.S. and global investors access to best-in-class investments in the U.S. medical devices, biotechnology, and digital health sectors ...See details»
Shangbay Capital - Investments, Portfolio & Company Exits
Shangbay Capital 's most notable exits include Ceribell, Berkeley Lights, and Lucira Health. Which industries has this organization had the most exits in? Show . Ceribell Ceribell focuses …See details»
ShangBay Capital investment portfolio | PitchBook
ShangBay Capital General Information Company Description. Founded in 2015, ShangBay Capital is a venture capital firm based in Palo Alto, California. The firm prefers to invest in …See details»
William Dai - shangbay-capital
William’s prior work experiences spanned more than 20 years in corporate finance, mergers and acquisitions, and capital markets in both Asia and the U.S. Prior to founding ShangBay Capital, he was the CFO of ShangPharma …See details»
Shangbay Capital - Funding, Financials, Valuation & Investors
Shangbay Capital has raised a total of $88.1M across 3 funds, their latest being ShangBay Capital III. This fund was announced on Apr 13, 2021 and raised a total of . obfuscated. …See details»
Philosophy - shangbay-capital
At ShangBay Capital, we have executed great deals, successfully helped startups commercialize their products, and expanded their business footprint. ShangBay has also established a …See details»
Shangbay Capital - CB Insights
ShangBay Capital is a premier medical technology focused venture capital firm based in Palo Alto, California founded in 2015. The venture firm focuses on investments in medical …See details»
ShangBay Capital: Fund Performance - PitchBook
ShangBay Capital General Information Description. ShangBay Capital is a 2015 vintage venture capital fund managed by ShangBay Capital. The fund is based in Palo Alto, California.See details»
ShangBay Capital on OpenVC
ShangBay Capital, founded in 2015 and based in Palo Alto, is a MedTech-focused venture firm. We specialize in disruptive technologies for unmet clinical needs, partnering with top teams …See details»
Shangbay Capital — 36 Investments, Portfolio, Team members
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Shangbay Capital, startups are often financed by Y Combinator, Medvance Incubator Partners, Data …See details»
Shangbay Capital Portfolio Companies - Crunchbase
Aug 19, 2015 This list of organizations invested in by Shangbay Capital provides data on their funding history, investment activities, and acquisition trends. Insights about top trending …See details»
Portfolio Companies - shangbay-capital
© 2024 ShangBay Capital. All Rights Reserved. bottom of pageSee details»
ShangBay Capital - Confluence.VC
ShangBay Capital is a venture capital firm that specializes in early stage and growth investments. Their focus is primarily in the life sciences sector, with a specific interest in biotechnology, …See details»
ShangBay Capital’s William Dai Recognized Among GrowthCap’s …
PALO ALTO, Calif., May 03, 2024--ShangBay Capital, a prominent venture capital firm specializing in healthcare investments, proudly announces the inclusion of William Dai in …See details»
ShangBay Capital’s William Dai Recognized Among GrowthCap
May 3, 2024 ShangBay Capital, a prominent venture capital firm specializing in healthcare investments, proudly announces the inclusion of William Dai in GrowthCap's esteemed list of …See details»
William Dai - ShangBay Capital - LinkedIn
Experienced Founding Partner with a demonstrated history of working in the venture… · Experience: ShangBay Capital · Education: Michigan State University - The Eli Broad Graduate School of ...See details»
News and Events - shangbay-capital
ShangBay Capital is proud to announce that Ceribell, one of our first portfolio companies, has filed for a $100 million IPO. Ceribell's pioneering AI-powered EEG platform is transforming …See details»
Founding Managing Partner @ Shangbay Capital - Crunchbase
William Dai serves as the Founding Managing Partner at ShangBay Capital. ... Number of Partner Investments 14. Announced Date . Organization Name . Investor Name . Lead Investor . …See details»
Paris dreams of becoming the capital of positive AI with the ...
22 hours ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»